Weather

89°F8:19 PM

Health

1 read

Financial Strain Linked to Accelerated Heart Aging, Study Reveals

KVIA•Friday, January 16, 2026 at 2:01 PM•CNN Newsource

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

AI Summary

A recent study published in the Mayo Clinic Proceedings indicates that financial stress and food insecurity may contribute to accelerated cardiovascular aging, potentially more so than traditional risk factors like high blood pressure and diabetes. Analyzing data from over 280,000 adults, researchers found that individuals experiencing financial strain exhibited signs of advanced heart aging, suggesting a significant impact on cardiovascular health. While financial stress does not guarantee heart disease, it adds to existing risks and underscores the importance of addressing social determinants of health. Experts recommend that healthcare providers consider financial stress in patient assessments and encourage practices that promote heart health.

Key Details: • Study involved over 280,000 adults assessing cardiovascular health and financial stress. • Financial stress can lead to structural changes in the cardiovascular system, increasing heart disease risk. • Clinicians should incorporate financial stress into patient evaluations for better health outcomes. • Maintaining a healthy lifestyle and managing stress can help mitigate heart health risks.

health research wellness cardiovascular financial-stress

People & Organizations

Dr. Leana WenMayo Clinic

Related Articles

Novo Nordisk Cuts Prices of Ozempic and Wegovy by 50% Starting 2027

Novo Nordisk has announced a significant reduction in the list prices of its popular diabetes and weight loss medications, Ozempic, Wegovy, and Rybelsus, by up to 50% starting in 2027. The current list price for Wegovy is $1,349, while Ozempic and Rybelsus are priced at $1,028. This price cut aims to improve accessibility for patients, particularly those with high deductibles or co-insurance plans. The move comes as Novo Nordisk competes with Eli Lilly, which has gained market share in the obesity medication sector. Despite the list price reductions, self-pay prices will remain unaffected. The company recently reported disappointing trial results for its next-generation obesity drug, contributing to a decline in its stock price.

Trump's Glyphosate Order Sparks Controversy Among Health Advocates in El Paso

An executive order by President Trump has declared glyphosate, a widely used herbicide, essential for national security and economic stability, which has drawn ire from health advocates, particularly those associated with the 'Make America Healthy Again' (MAHA) movement. The order emphasizes the need for a domestic supply of glyphosate, despite ongoing health concerns about its potential carcinogenic effects. Critics, including Zen Honeycutt of Moms Across America, argue that this move may protect Monsanto from lawsuits related to glyphosate's health risks. The order coincides with Bayer's proposed $7.25 billion settlement over cancer claims linked to Roundup, the product containing glyphosate. Health experts warn of the herbicide's risks, especially to children, as studies indicate increased cancer risks associated with exposure.

How Technology is Enhancing Patient Engagement in Healthcare

Recent advancements in technology are significantly improving the way patients interact with their healthcare providers. Tools like home blood pressure monitors, glucometers, and smartwatches allow patients to collect vital health data, which can be shared during appointments to enhance treatment plans. For example, accurate blood pressure readings require validated devices and specific techniques to ensure reliability. This shift towards patient-generated data is transforming healthcare from a reactive to a proactive model, enabling more personalized care. However, while technology plays a crucial role, it is essential to maintain the personal connection during in-person visits.

El Paso Matters•Feb 23

El Paso Researchers Investigate Natural Remedies for Cancer and Heart Disease

Researchers at Texas Tech Health El Paso are exploring innovative treatments for pancreatic cancer and heart disease, targeting health issues prevalent in the community. Dr. Ramadevi Subramani Reddy is studying gedunin, a compound from the neem tree, with a $45,000 grant aimed at reducing the toxic side effects of chemotherapy. Pancreatic cancer affects El Pasoans at a rate of 8.8 per 100,000, highlighting the urgency for new therapies. Meanwhile, Dr. Kazue Okajima is analyzing blood thinners to improve survival rates for heart disease patients, supported by a $36,000 grant. The Lizanell and Colbert Coldwell Foundation has significantly contributed to these research efforts, totaling over $1.6 million since 1991.